Alexis, an accomplished leader in the field, currently holds the position of Senior Director of Operational Strategy at Precision for Medicine, where she plays a pivotal role in navigating the complex landscape of global oncology and rare disease-focused clinical trials. With a career spanning over 15 years in the clinical trials industry, Alexis brings a wealth of experience across multiple therapeutic areas, showcasing her proficiency in diverse aspects of operational strategy. Her primary focus remains in the realm of oncology, demonstrating a deep understanding cultivated through specialization in early phase adaptive studies, particularly within the realms of Immuno-oncology and Advanced therapeutics. Her academic background, consisting of an MSc in Neuroscience and an MA in Biotechnology Law and Ethics, further underscores her commitment to excellence in the industry.
Prior to Precision for Medicine, Alexis has played instrumental roles in various capacities at both pharmaceutical and biotechnology companies, such as Gilead, Allergan, Amgen and Genmab, solidifying her reputation as a versatile and accomplished professional.